Market Overview:
The global clinical mass spectrometry service market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing demand for advanced diagnostic services, rising prevalence of chronic diseases, and technological advancements in the field of mass spectrometry. Based on type, the global clinical mass spectrometry service market is segmented into newborn genetic and metabolic disease screening, vitamins and hormones, therapeutic drug testing, microbial identification, and other segments. The newborn genetic and metabolic disease screening segment accounted for the largest share of the global clinical mass spectrometry service market in 2017. This segment is expected to grow at a CAGR of 8% from 2018 to 2030 due to increasing demand for early diagnosis of genetic disorders in newborns. Based on application, the global clinical mass spectrometry service market is divided into hospital-based applications and health center-based applications.
Product Definition:
Clinical mass spectrometry service is a laboratory technique that is used to measure the protein and peptide composition of biological samples. The importance of clinical mass spectrometry service lies in its ability to provide detailed information about the proteins present in a sample, which can be used to diagnose diseases or monitor treatment responses.
Newborn Genetic and Metabolic Disease Screening:
Newborn genetic and metabolic disease screening, it's usage.
The global newborn genetic and metabolic disease screening, its usage & growth factors in clinical mass spectrometry service market size was valued at USD 2.2 billion in 2016. It is anticipated to expand at a CAGR of XX% during the forecast period.
Vitamins and Hormones:
Vitamins and hormones and it's usage in clinical mass spectrometry service market is expected to grow at a lucrative rate during the forecast period. The growth of this market can be attributed to factors such as increasing awareness about maintaining health, rising geriatric population base, growing incidences of chronic diseases due to changing lifestyles, unhealthy food habits along with increased stress levels.
Global Vitamins and Hormones.
Application Insights:
The hospital segment dominated the global clinical mass spectrometry service market in 2017. This can be attributed to factors such as increasing prevalence of chronic diseases and rising demand for targeted drug therapies. For instance, according to WHO, in 2016 approximately 1 billion adults were suffering from some form of diabetes and this number is expected to reach about 2 billion by 2050 if preventive measures are not taken. Thus, an increase in the incidence rate of chronic diseases results in increased demand for targeted drug therapies which eventually boosts the adoption of LCMS services at a national level as well as individual hospitals/healthcenters.
LCMS has been proven beneficial at a hospital level due to its ability to provide sensitive and specific diagnosis with high accuracy levels within short timeframes that were not possible before its introduction (Sanchez et al., 2012). It also helps reduce turnaround time while handling large volumes resulting in improved patient care (Kumar et al., 2014; Sanchez et al., 2012).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of global players, increasing adoption of advanced technologies, and high healthcare expenditure in this region. In addition, newborn screening programs conducted by public health agencies such as Canada Health Infoway and National Public Health System (NPHSS) have increased awareness about genetic disorders among parents which is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income leading to improved accesses for diagnosis & treatment coupled with growing prevalence rates for various infectious diseases such as dengue fever and chikungunya virus infection. These factors are expected contribute towards regional demand during the forecast period.
Growth Factors:
- Increasing demand for personalized medicine
- Growing number of clinical trials
- Rising prevalence of chronic diseases
- Technological advancements in mass spectrometry instruments and software
- Growing awareness about the benefits of mass spectrometry services
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Mass Spectrometry Service Market Research Report
By Type
Newborn Genetic and Metabolic Disease Screening, Vitamins and Hormones, Therapeutic Drug Testing, Microbial Identification, Other
By Application
Hospital, Health Centre, Other
By Companies
Guangzhou Kingmed, Dian Diagnostics Group, Da An Gene Co, Guangzhou Huayin Medical, Beijing Harmony Health Medical, BGI Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
180
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Mass Spectrometry Service Market Report Segments:
The global Clinical Mass Spectrometry Service market is segmented on the basis of:
Types
Newborn Genetic and Metabolic Disease Screening, Vitamins and Hormones, Therapeutic Drug Testing, Microbial Identification, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Health Centre, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Guangzhou Kingmed
- Dian Diagnostics Group
- Da An Gene Co
- Guangzhou Huayin Medical
- Beijing Harmony Health Medical
- BGI Group
Highlights of The Clinical Mass Spectrometry Service Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Newborn Genetic and Metabolic Disease Screening
- Vitamins and Hormones
- Therapeutic Drug Testing
- Microbial Identification
- Other
- By Application:
- Hospital
- Health Centre
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Mass Spectrometry Service Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clinical Mass Spectrometry Service is a service that provides mass spectrometry-based analysis of biological specimens for the diagnosis and treatment of diseases.
Some of the key players operating in the clinical mass spectrometry service market are Guangzhou Kingmed, Dian Diagnostics Group, Da An Gene Co, Guangzhou Huayin Medical, Beijing Harmony Health Medical, BGI Group.
The clinical mass spectrometry service market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Mass Spectrometry Service Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clinical Mass Spectrometry Service Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clinical Mass Spectrometry Service Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clinical Mass Spectrometry Service Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clinical Mass Spectrometry Service Market Size & Forecast, 2018-2028
4.5.1 Clinical Mass Spectrometry Service Market Size and Y-o-Y Growth
4.5.2 Clinical Mass Spectrometry Service Market Absolute $ Opportunity
Chapter 5 Global Clinical Mass Spectrometry Service Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Clinical Mass Spectrometry Service Market Size Forecast by Type
5.2.1 Newborn Genetic and Metabolic Disease Screening
5.2.2 Vitamins and Hormones
5.2.3 Therapeutic Drug Testing
5.2.4 Microbial Identification
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Clinical Mass Spectrometry Service Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Clinical Mass Spectrometry Service Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Health Centre
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clinical Mass Spectrometry Service Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clinical Mass Spectrometry Service Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Clinical Mass Spectrometry Service Analysis and Forecast
9.1 Introduction
9.2 North America Clinical Mass Spectrometry Service Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Clinical Mass Spectrometry Service Market Size Forecast by Type
9.6.1 Newborn Genetic and Metabolic Disease Screening
9.6.2 Vitamins and Hormones
9.6.3 Therapeutic Drug Testing
9.6.4 Microbial Identification
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Clinical Mass Spectrometry Service Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Health Centre
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Clinical Mass Spectrometry Service Analysis and Forecast
10.1 Introduction
10.2 Europe Clinical Mass Spectrometry Service Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Clinical Mass Spectrometry Service Market Size Forecast by Type
10.6.1 Newborn Genetic and Metabolic Disease Screening
10.6.2 Vitamins and Hormones
10.6.3 Therapeutic Drug Testing
10.6.4 Microbial Identification
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Clinical Mass Spectrometry Service Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Health Centre
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Clinical Mass Spectrometry Service Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Clinical Mass Spectrometry Service Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Clinical Mass Spectrometry Service Market Size Forecast by Type
11.6.1 Newborn Genetic and Metabolic Disease Screening
11.6.2 Vitamins and Hormones
11.6.3 Therapeutic Drug Testing
11.6.4 Microbial Identification
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Clinical Mass Spectrometry Service Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Health Centre
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Clinical Mass Spectrometry Service Analysis and Forecast
12.1 Introduction
12.2 Latin America Clinical Mass Spectrometry Service Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Clinical Mass Spectrometry Service Market Size Forecast by Type
12.6.1 Newborn Genetic and Metabolic Disease Screening
12.6.2 Vitamins and Hormones
12.6.3 Therapeutic Drug Testing
12.6.4 Microbial Identification
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Clinical Mass Spectrometry Service Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Health Centre
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Clinical Mass Spectrometry Service Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Clinical Mass Spectrometry Service Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Clinical Mass Spectrometry Service Market Size Forecast by Type
13.6.1 Newborn Genetic and Metabolic Disease Screening
13.6.2 Vitamins and Hormones
13.6.3 Therapeutic Drug Testing
13.6.4 Microbial Identification
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Clinical Mass Spectrometry Service Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Health Centre
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clinical Mass Spectrometry Service Market: Competitive Dashboard
14.2 Global Clinical Mass Spectrometry Service Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Guangzhou Kingmed
14.3.2 Dian Diagnostics Group
14.3.3 Da An Gene Co
14.3.4 Guangzhou Huayin Medical
14.3.5 Beijing Harmony Health Medical
14.3.6 BGI Group
